Bureau Veritas SA (EPA:BVI) Just Released Its Half-Year Earnings: Here's What Analysts Think

Simply Wall St

Bureau Veritas SA (EPA:BVI) came out with its half-year results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report. It was a credible result overall, with revenues of €3.2b and statutory earnings per share of €1.25 both in line with analyst estimates, showing that Bureau Veritas is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

ENXTPA:BVI Earnings and Revenue Growth July 28th 2025

Following last week's earnings report, Bureau Veritas' 14 analysts are forecasting 2025 revenues to be €6.52b, approximately in line with the last 12 months. Statutory earnings per share are forecast to dip 8.1% to €1.36 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of €6.54b and earnings per share (EPS) of €1.36 in 2025. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

See our latest analysis for Bureau Veritas

It will come as no surprise then, to learn that the consensus price target is largely unchanged at €33.95. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Bureau Veritas, with the most bullish analyst valuing it at €38.50 and the most bearish at €28.50 per share. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

Of course, another way to look at these forecasts is to place them into context against the industry itself. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 3.0% by the end of 2025. This indicates a significant reduction from annual growth of 7.8% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.2% per year. It's pretty clear that Bureau Veritas' revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Bureau Veritas' revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Bureau Veritas going out to 2027, and you can see them free on our platform here..

You still need to take note of risks, for example - Bureau Veritas has 2 warning signs we think you should be aware of.

Valuation is complex, but we're here to simplify it.

Discover if Bureau Veritas might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.